Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiming prescription (益鸣方) is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Traditional Chinese Medicine Hospital for the treatment of idiopathic tinnitus. It is formulated based on the TCM therapeutic principle of 'invigorating the spleen, tonifying the kidney, and dredging the orifices' (健脾补肾通窍). The prescription is intended to improve hearing symptoms and quality of life by addressing systemic imbalances believed to cause tinnitus. It is currently being evaluated in clinical trials in combination with Yifeng (TE17) acupoint injections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiming prescription.